1985. A Prospective, Randomized Trial to Assess a Protease Inhibitor–based Regimen Switch Strategy to Manage Integrase Inhibitor–related Weight Gain

BACKGROUND: Integrase inhibitor (INI)–based antiretroviral (ARV) therapies are associated with greater weight gain than non-nucleoside reverse transcriptase inhibitor– or boosted protease inhibitor–based regimens, disproportionately affecting Black and Hispanic individuals and women. The mechanisms...

Descripción completa

Detalles Bibliográficos
Autores principales: Short, William R, Ramgopal, Moti, Hagins, Debbie P, Lee, Johnnie, Bruce Simonson, Richard, Hsu, Tien-Huei, Xu, Ping, Anderson, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677970/
http://dx.doi.org/10.1093/ofid/ofad500.112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677970/
http://dx.doi.org/10.1093/ofid/ofad500.112

Ejemplares similares